Two major RCTs investigating the OTSC system in first-line therapy were presented at this year’s UEG Week, both demonstrating that OTSC is the superior therapy for first-line treatment of non-variceal upper GI bleeding.
The presentations are summarized in this report: Congress report UEG Week Virtual 2021
– OTSC treatment can be considered as the first-line treatment for larger peptic ulcers. The cost to avert further bleeds was cheaper with use of OTSC. – James Lau (Hong Kong)
– OTSC first-line therapy is superior to standard treatment in patients with acute NVUGIB and high-risk of rebleeding. – Benjamin Meier (Ludwigsburg, Germany)